K
KRM Ayurveda
KRMAYURVED NSE
KRM Ayurveda
HealthcareNSE: KRMAYURVED Pharmaceuticals
Key Fundamentals
SMEPharmaceuticalsHealthcareMarket Cap
₹596 Cr
Volatility
Moderate
P/E Ratio
0
EBITDA
₹30.50 Cr
Return on Equity
50.67%
Debt to Equity
1.28
Book Value
₹56.55
52W High
₹343.95
52W Low
₹156.15
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view KRM Ayurveda insights
28 extracted metrics + investor summaries across FY23–FY25.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Growth Rate
Revenue Growth
32.24% ↗
Net Income Growth
64.13% ↗
Cash Flow Change
96.63% ↗
ROE
74.91% ↗
ROCE
107.73% ↗
EBITDA Margin (Avg.)
17.59% ↗
Quarterly Results
| Sep 2025 | |
|---|---|
| Sales | 48 |
| Expenses | 36 |
| Operating Profit | 13 |
| OPM % | 27% |
| Other Income | 0 |
| Interest | 2 |
| Depreciation | 1 |
| PBT | 11 |
| Tax % | 26% |
| Net Profit | 8 |
| EPS in Rs | 5.24 |
Profit & Loss
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Sales | 89 | 67 | 77 |
| Expenses | 78 | 60 | 57 |
| Operating Profit | 11 | 8 | 19 |
| OPM % | 13% | 11% | 25% |
| Other Income | 0 | 0 | 0 |
| Interest | 1 | 2 | 2 |
| Depreciation | 1 | 1 | 1 |
| PBT | 10 | 5 | 16 |
| Tax % | 25% | 28% | 26% |
| Net Profit | 8 | 3 | 12 |
| EPS in Rs | 5,067 | 2,273 | 807 |
| Div. Payout % | 0% | 0% | 0% |
Balance Sheet
| Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|
| Equity Capital | 0.15 | 0.15 | 0.15 | 16 |
| Reserves | 8 | 12 | 24 | 21 |
| Borrowings | 20 | 23 | 31 | 25 |
| Other Liabilities | 11 | 9 | 12 | 17 |
| Total Liabilities | 39 | 44 | 67 | 78 |
| Fixed Assets | 23 | 23 | 27 | 27 |
| CWIP | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 |
| Other Assets | 16 | 21 | 40 | 52 |
| Total Assets | 39 | 44 | 67 | 78 |
Cash Flow
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Operating | 4 | -1 | 0 |
| Investing | -23 | 0 | -4 |
| Financing | 19 | 1 | 6 |
| Net Cash Flow | 0 | 0 | 2 |
Ratios
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Debtor Days | 32 | 30 | 58 |
| Inventory Days | 13 | 53 | 296 |
| Days Payable | 100 | 141 | 205 |
| Cash Conversion Cycle | -55 | -58 | 149 |
| Working Capital Days | 9 | 48 | 64 |
| ROCE % | — | 22% | 42% |
Documents
1
Reply to Clarification- Financial results
27 July 2026 - KRM Ayurveda filed missing FY26 financial result clarifications, working capital certificate, and unmodified audit opinion. 27 July 2026 - KRM Ayurveda filed missing FY26 financial result clarifications, working capital certificate, and unmodified audit opinion.
2
Analysts/Institutional Investor Meet/Con. Call Updates
22 July 2026 - KRM Ayurveda disclosed outcome of a virtual analyst/investor group meet on July 24, 2026. 22 July 2026 - KRM Ayurveda disclosed outcome of a virtual analyst/investor group meet on July 24, 2026.
3
Updates
20 July 2026 - Board approved sale of non-operational Delhi property for about ₹3.5 crore on 20 July 2026. 20 July 2026 - Board approved sale of non-operational Delhi property for about ₹3.5 crore on 20 July 2026.
4
Analysts/Institutional Investor Meet/Con. Call Updates
16 July 2026 - KRM Ayurveda scheduled an investor/analysts group meeting on July 20, 2026 at 4:00 pm via audio/video. 16 July 2026 - KRM Ayurveda scheduled an investor/analysts group meeting on July 20, 2026 at 4:00 pm via audio/video.
5
Analysts/Institutional Investor Meet/Con. Call Updates
16 July 2026 - Investor/analyst meeting rescheduled to July 21, 2026 at 11:30 am via audio/video. 16 July 2026 - Investor/analyst meeting rescheduled to July 21, 2026 at 11:30 am via audio/video.
Frequently Asked Questions about KRM Ayurveda
Where is KRM Ayurveda (KRMAYURVED) listed?
KRM Ayurveda is listed on the Indian stock exchanges. It is listed on NSE: KRMAYURVED. You can view its live share price, financials, and ratios on Tapetide.
Which sector does KRM Ayurveda belong to?
KRM Ayurveda operates in the Healthcare sector within the Pharmaceuticals industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of KRM Ayurveda?
KRM Ayurveda has a market capitalisation of approximately ₹596.37 Cr. Based on this, it is classified as a Small Cap stock.
What is the PE ratio of KRM Ayurveda?
The Price-to-Earnings (PE) ratio of KRM Ayurveda is 0.00. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of KRM Ayurveda?
Over the past 52 weeks, KRM Ayurveda has traded between a low of ₹156.15 and a high of ₹343.95. This range helps investors understand the stock's price volatility and recent trading levels.
What is the Return on Equity (ROE) of KRM Ayurveda?
KRM Ayurveda has a Return on Equity (ROE) of 50.67%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research KRM Ayurveda on Tapetide?
On Tapetide, you can view KRM Ayurveda's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.
Company Information
Listed 2026-01-29